Cabaletta Bio, Inc. (CABA) vs ClearPoint Neuro, Inc. (CLPT)

A side-by-side comparison of Cabaletta Bio, Inc. and ClearPoint Neuro, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CABA vs CLPT

growth of $100 · dividends reinvested · last 7y
CABA -79.2% (-20.1%/yr)CLPT +178.9% (+15.8%/yr)CLPT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120232025$21$279
CABA CLPT

CABA vs CLPT: by the numbers

  • •CLPT is the larger company ($327M vs $326M market cap).
  • •Both run net losses; CABA's is the smaller (0.00% vs -81.76% net margin).

Metrics side by side

Valuation

MetricCABACLPT
P/S ratioN/A7.73
P/B ratio1.5530.33

Profitability

MetricCABACLPT
Gross margin0.00%62.61%
Operating margin0.00%-65.36%
Net margin0.00%-81.76%
ROE-86.10%-320.77%
ROIC-85.56%-40.51%

Growth (annualized)

MetricCABACLPT
Revenue CAGR (5Y)N/A23.57%
Total return CAGR (5Y)-28.71%-7.65%

Frequently asked

How have CABA and CLPT total returns compared?
Over the past 5 years, CABA delivered -28.71% and CLPT delivered -7.65% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.